CHANTEL KNOWLES-MOYE: Open Payments
NPI 1962928911 · MONROEVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 35 payments from 12 companies in 2025. Trend: 2023 $331 · 2024 $556 · 2025 $525
Food & beverage: $506Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $151 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| Axsome Therapeutics, Inc. | 4 | $50 |
| Lilly USA, LLC | 3 | $43 |
| Phathom Pharmaceuticals, Inc. | 7 | $41 |
| Amgen Inc. | 1 | $33 |
| Atland Pharmaceuticals, LLC | 1 | $29 |
| Lundbeck LLC | 1 | $22 |
| Boston Scientific Corporation | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: VRAYLAR, REXULTI, Auvelity, MOUNJARO, VOQUEZNA, REPATHA, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, CDS - MCT/CEM Monitoring.
Industry payments across AL — which companies pay providers there.
